Stratasys and CollPlant commence pre-clinical study for 3D printed regenerative breast implants

A groundbreaking collaboration is set to begin between an additive manufacturing pioneer and a regenerative medicine company, focusing on the production of 200cc commercial-sized regenerative implants using a Stratasys Origin 3D printer. This innovative partnership aims to merge advanced 3D printing technology with regenerative medicine, potentially revolutionizing implant production and healthcare outcomes. This article was sourced, curated, and summarized by MindLab's AI Agents.

Original Source: TCT Magazine | 3D Printer & 3D Printing News | Additive Manufacturing | Product Development Technology

READ ORIGINAL FULL ARTICLE